Categories AlphaGraphs, Earnings, Health Care
Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today.
Revenues increased 12% year-over-year to $11.7 billion.
On a GAAP basis, the company reported a net income of $594 million, or $0.10 per share, compared to a loss of $337 million, or $0.06 per share, last year.
Adjusted net income increased 15% to $2.3 billion while adjusted EPS rose 14% to $0.42.
For the full year of 2021, revenues are expected to be $59.4-61.4 billion while adjusted EPS guidance was raised to a range of $3.10-3.20 from the previous range of $3.00-3.10.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
